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Executive Summary
This paper discusses how an evaluation was done on a peer cancer support group, Cancer
Awareness Resource and Education (CARE). The peer cancer support group, CARE, is the only cancer
support group provided at Zuckerberg San Francisco General Hospital and Trauma Center (ZSFG), San
Francisco City and County’s safety-net hospital. ZSFG serves a large underserved population such as
those who are low-income, racial and ethnic minorities, and struggling with a medical condition.
Evaluation is pertinent to understanding the efficacy of the program and to gaining support for the
program’s continual existence.
The evaluation included in-depth interviews with CARE participants to understand what is most
valued and gained from participating in the program. Social support was a common theme that emerged
in the analysis of the interviews, so pre-survey and post-survey were created to measure perceived social
support and to take inventory of health-related benefits from participating in CARE. Due to the timing
of the fieldwork, data from the post survey has not yet been collected, but the method of creating the
evaluation, the in-depth interview findings, and the pre-survey findings are reported. Results from this
project will be provided to CARE management to improve programing of CARE and to substantiate the
continual support for the CARE program.
This paper recommends evaluation methods and tools to evaluate CARE’s efficacy. In-depth
interviews and short, simply worded in-session paper surveys examining perceived social support are
recommended for CARE. This paper also recommends further research and advancements toward
creating best practices for peer cancer support group evaluations. To improve peer support group
evaluation methods and tools, all stakeholders especially cancer survivor participants need to be
involved.
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Abstract
Introduction: For many years, health care organizations have offered peer cancer support groups to
cancer survivors, but peer cancer support group evaluation is not standardized. Without a clear and
consistent evaluation, it may be difficult to understand the efficacy of and gain support for peer cancer
support groups. In this paper, I discuss how an evaluation was created for a peer cancer support group
called Cancer Awareness Resource and Education (CARE).
Methods: In-depth interviews with CARE participants were conducted and pre-survey and a postsurvey were developed. The in-depth interviews included a convenience sample of eight individuals,
two individuals from the following ethnic groups: African/African American, Asian/Pacific Islander,
Caucasian, and Latino/Chicano. A pre-survey was also piloted on 25 CARE participants during a
seminar.
Results: Social support was highly valued by CARE participants, with interviewees stating they came to
CARE to meet other cancer survivors, they gain social support, and they continued to come to obtain
additional social support. Since social support was commonly valued, a pre-survey and post-survey was
created to measure social support.
Discussion: Conducting qualitative interviews to help create quantitative surveys seemed to be most
effective for this project since no standardized peer cancer support evaluation method or tool exist.
Social support seemed to be highly valued and leveraged in CARE, and should be the focus of future
evaluation of cancer peer support groups.
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Cancer survivorship is an emerging area of care that has been driven by improved survival in the
face of a historically deadly disease. Cancer forms when abnormal, old, or damaged cells divide without
control, losing its functionality (NCI, 2015). Cancer can start almost anywhere in the body, can spread,
and can lead to death (NCI, 2015). In the past cancer was regarded as a death sentence, but that has
changed with cancer survival improving. It was estimated 13.7 million Americans were living with a
history of cancer in 2012; that number is expected to be 18 million by 2020 (Siegel et al., 2012). There
is a large population of people living with a history of cancer, and they are now tending to live longer.
Since 1974, 5-year survival for the most common types of cancer combined has increased (Jemal, et al.,
2017). The majority of cancer survivors, about 67%, were diagnosed 5 or more years ago, and 17% were
diagnosed 20 or more years ago (American Cancer Society, 2016).
As cancer survival has improved, a definition of a cancer survivor has emerged. The National
Coalition for Cancer Survivorship selected the words “cancer survivor” to convey two important
messages: a message of hope for life after cancer, and a message to consider what happens beyond
treatment (Ullman, 2014). Since there are more and more cancer survivors that need help beyond
treatment, it seems pertinent to discuss cancer support that goes beyond medical intervention.
One way to provide support to cancer survivors is to offer a cancer support group. This paper
will discuss first, how a cancer survivor peer support group was evaluated and second, will provide
recommendations on method and tools for future evaluations and on program improvement.
Literature Review
Being a cancer survivor is at the forefront of my self-awareness. It enters into the conversations
that I have with myself about what I want to do, how I want to spend money, how I want to spend
time, my energy, all of that. Being a cancer survivor has added another dimension to my identity.
I am a cancer survivor. — Dr. Mortimer Brown, 80, colorectal cancer survivor diagnosed
(President’s Cancer Panel, 2004)
Evolution of Cancer Survivor Definition
Cancer survivorship is expanding and still being understood. Even the definition of a cancer
4
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cancer was considered incurable, the term “survivors” was used to describe family members who
experienced the loss of loved ones to cancer (Leigh, 1996). As cancer survival increased, physicians
used the term “cancer survivor” to describe a person surviving cancer for five years or more after
diagnosis or treatment (Leigh, 1996). The National Coalition for Cancer Survivorship (NCCS) does not
use a five-year cancer survival condition. According to the NCCS, people are cancer survivors from the
time they are diagnosed with cancer until the time they die (NCCS, 2014). The National Cancer Institute
(NCI) has expanded the definition of cancer survivors to include people such as caregivers and family
members who are affected by the cancer of loved ones (Aziz, 2002). For this paper, I will use the
NCCS’s definition of cancer survivor. I will refer to people diagnosed with cancer as cancer survivors
from the time of diagnosis on.
Cancer Incidence and Survival in the San Francisco Bay Area
Cancer is a prevalent disease not only in the United States, but also in the San Francisco Bay
Area. In the San Francisco Bay Area, the five most common invasive cancers are: breast, prostate, lung
and bronchus, colorectal, and melanoma cancer (Cancer Prevention Institute of California, 2016).
Cancer kills more San Franciscans than any other cause (Hiatt & Ashworth, 2016). From 2009-2013,
San Francisco cancer incidence rate has been 420.9 per 100,000 people (San Francisco Health
Improvement Partnership, 2016a). From 2012-2014, San Francisco all cancer mortality rate has been
135.5 per 100,000 people, a decrease from 151.2 per 100,000 in 2009-2011 (San Francisco Health
Improvement Partnership, 2016b). Fortunately, mortality rates in San Francisco have trended downward
since 2009 (San Francisco Health Improvement Partnership, 2016b). There is a decrease in mortality and
an increase in cancer survivors in San Francisco. According to Surveillance Epidemiology and End
Results, NCI’s cancer registry of several states and two major metropolitan areas including SanFrancisco-Oakland, there is an upward trend in the number of cancer survivors in the San Francisco Bay
Area (Parry, Kent, Mariotto, Alfano, & Rowland, 2011). Given that the cancer survivor population is
5
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Physical Effects
People with cancer can improve their survival with diagnosis and treatment, but there are
subsequent physical side effects from these interventions. Most cancers are given a diagnosis and stage
(Cancer Research UK, 2014a). There are generally four stages: stage I includes small primary tumors
that have not spread to other organs; Stage II and III include larger or more extensive primary tumors
with or without cancer in nearby organs; Stage IV includes cancer that has spread from where it
originated to other organs (Cancer Research UK, 2014b). Medical interventions are generally
determined by type and stage of cancer, possible side effects, patient preferences, and overall patient
health (Blinman, King, Norman, Viney, & Stockler, 2012). Some common cancer treatments are
surgery, chemotherapy, and radiation. Undergoing cancer treatments may be difficult depending on the
factors stated above because there are a variety of subsequent side effects. According to the National
Cancer Institute, there are numerous common physical side effects from cancer treatment are anemia,
appetite loss, bleeding and bruising, constipation, delirium, diarrhea, edema, fatigue, hair loss, infection
and neutropenia, lymphedema, memory or concentration problems, mouth and throat problems, nausea
and vomiting, nerve problems, pain, sexual and fertility problems, skin and nail change, sleep problems,
and urinary and bladder problems.
Emotional Effects
In addition to physical side effects, studies have shown serious emotional effects from having
cancer. According to the American Cancer Society, most people faced with cancer experience some
degree of depression, anxiety, fear, or distress. Prevalence is estimated to be between 10% and 25% for
major depressive disorder (Pirl, 2004). Diagnosable anxiety disorders are estimated to be 10%-30% in
cancer survivors (Greer et al., 2011). Distresses can span from before to even after cancer treatment. A
study found that 51% of newly diagnosed lung cancer patients reported clinically significant distress on
the Distress Thermometer (Steinberg et al., 2009). Another study found that the prevalence rate of breast
6
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Studts, & Miller, 1998).
Understanding the Multiple Effects of Cancer
Cancer survivors are dealing with multiple serious issues. Testimony from cancer survivors can
better describe the depth of distress. Cancer survivors provided testimonies to the President of the
United States of America through the President’s Cancer Panel to explain the immense challenges
cancer survivors face. In the following testimony, a cancer survivor described her anxiety of cancer
recurrence and cancer treatment complications even many years after treatment.
My concerns as a survivor have evolved the farther away I have gotten from treatment… During
my treatment and for several years after...my primary concern was recurrence… [Now] I worry
about secondary cancers...and problems due to my [treatment]... I am in premature menopause
because of the high doses of chemotherapy I received, so I worry about osteoporosis, sexuality,
cardiac problems, and yes, even wrinkles. —Karen Dyer, 24, rhabdomyosarcoma survivor
(President’s Cancer Panel, 2004)
Cancer survivors experience a considerable amount of physical and emotional issues relating to cancer
that begins from the time of diagnosis on. There are even issues that are beyond physical and emotional
problems that complicate multiple parts of life and overall quality of life. The follow testimony is from a
cancer survivor who is a mother and head of household.
[My husband] decided to move on. I had three young children depending on me. There was no
room for me to be sick but I didn’t have a choice... The ‘repo’ man came to take our car… [My
kids] did odd jobs so that I could have the gas money to go back and forth [to treatment]… I
became so depressed until I just didn’t want to live anymore… [My kids said,] ‘You can’t give
up. You have come so far… — Barbara Young, 50, breast and stomach cancer survivor,
diagnosed at ages 34, 41, and 44 (President’s Cancer Panel, 2004)
In the case of this cancer survivor, cancer also affected her family relationships, her financial stability,
and even her identity as a mother and provider to her children. Cancer can affect a person’s overall
quality of life. According to the Centers of Disease Control and Prevention, the diagnosis of cancer is a
threat to a cancer survivor’s physical, psychological, social, spiritual, and economic wellbeing (Centers
of Disease Control and Prevention, 2014). The impact cancer has on cancer survivors’ overall wellbeing
and quality of life can make cancer survivors very vulnerable.
7
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The unique vulnerabilities of cancer survivors suggest they may need several avenues of help.
One avenue of assistance can be through cancer support groups. There are several types of cancer
support groups. Cancer support groups may be convened in person, on the web, or on the telephone.
Cancer support groups can be lead by medical professionals, a fellow cancer survivor described in this
paper as a peer, or another type of person. For this project, I will focus on in-person peer cancer support
groups. Cancer support groups can serve various purposes depending on the design, vision, mission, and
goals of the program.
The Purpose of Cancer Support Group Evaluations
Cancer support group evaluations can be a good way to know how cancer survivors are faring in
various aspects of life, and to know how cancer support groups are helping its cancer survivor members.
Evaluations such as process and outcome evaluations on cancer support group participants can measure
respectively how cancer survivors are improving while participating in the cancer support group and
how cancer survivors are doing overall. Cancer support group evaluations can also be an ideal way to
obtain cancer survivorship information by providing institutions a large and convenient sample of cancer
survivors.
Evaluation Methods
There are many ways evaluations on can be done on cancer support groups. Three main methods
of evaluations exist: qualitative, quantitative, and mixed-methods that use both quantitative and
qualitative methods. Quantitative data involves numbers while qualitative data involves words, videos,
and pictures. Quantitative data usually is collected from a larger sample of people compared to
qualitative data, but qualitative data captures people’s voices and detailed explanations (Lee, 2013).
Both qualitative and quantitative data are valuable, but decision makers tend to like quantitative data
(Lee, 2013). According to a systematic review on peer cancer support groups, there is a lack of guidance
on evaluations; therefore, it may be unclear how to conduct a rigorous evaluation (Campbell, Phaneuf,
8
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Quantitative Survey Tools
There are several quantitative survey tools used by cancer support programs like those presented
in Table 1. The survey tools in Table 1 were selected for presentation because they are commonly used
to measure multiple aspects of life. According a national survey on patient navigation and cancer
survivorship programs, the National Cancer Network Distress thermometer is the most common
assessment tool used in about 50% of patient navigation and cancer survivorship programs (George
Washington Cancer Institute, 2013). An authority in cancer, National Comprehensive Cancer Network,
provides the National Comprehensive Cancer Network Distress Thermometer to help cancer survivors
describe the distress they are feeling. Though this is popular, it only allows cancer survivors to provide
one overall score to describe their distress. It is not granular enough to pick smaller changes and it may
not be suitable for a pretest and posttest evaluation design. Functional Assessment of Cancer Therapy –
General(FACT-G) is a survey used in about 8% of cancer patient navigation and cancer survivorship
programs (George Washington Cancer Institute, 2013). FACT-G evaluates health-related quality of life
Table 1
Example Survey Tools
Survey Tools
National Comprehensive Cancer Network
Distress Thermometer
FACT-G
EORTC Quality of Life Questionnaire C30

Source
Jacobsen, et. al., 2005
Winstead-Fry & Schultz, 1997
Aaronson, et al, 1993
Bruera, Kuehn, Miller, Selmser, &

Edmonton Symptom Assessment System
(ESAS)
SF-12 Health survey
Quality of Life Patient/Cancer Survivor
Version (QOL-CSV)

Macmillan, 1991
Ware, Kosinski, & Keller, 1996
Ferrell, B.,. et al, 2012
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granular chances, but it does not measure spiritual and financial wellbeing. Like FACT-G, other surveys
ask several questions with a Likert scale, but may not cover all five dimensions of wellbeing affected by
cancer as described by the CDC. The only survey listed that uses a Likert scale and measures all five
dimensions of wellbeing is the Quality of Life Patient/Cancer Survivor Version (Ferrell, B., HasseyDow, K., Grant, M. et al, 2012). Unfortunately, literature has not found it to be a common survey tool
used to evaluate cancer support groups.
Lack of Standardized Qualitative Survey Tools
Though there are many survey tools to assess cancer support programs that capture various
aspects of cancer survivorship, no one survey clearly prevails, is deemed superior over all others, and is
commonly used. The National Cancer Institute’s measures database currently lists 192 survey tools
relating to cancer survivorship. In the database the tools can be reviewed and rated up to five stars, but
only 4 survey tools currently have five stars with only one to four reviewers. This may indicate that
there are many survey tools and little consensus on what survey tool is best. The Malin, Sayers, and
Jefford 2011 study on quality of cancer care corroborates this by concluding that there is currently is no
set of validated survey tools specific to cancer survivorship. In addition to this, the American Society of
Clinical Oncology states that there is a lack of guidance for assessment and management for long-term
cancer survivorship support, and suggests that a standardized outcome measure is needed. A systematic
review on the efficacy of cancer peer support groups specifically states, “This field would also benefit
from more consistent use of standard outcome measures” (Campbell, Phaneuf, Deane, & 2004). Another
systematic view on cancer support groups finds little research specifically on the effectiveness of peer
support groups, and urges for more studies (Hoey, Ieropoli, White, Jefford, 2008). Currently, there
seems to be no standard way to precisely evaluate how cancer survivors are doing. To date, there seems
to be no standardized tools to rigorously and accurately assess the efficacy of peer cancer support
groups.
10
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The Cancer Awareness, Resources, and Education (CARE) provides a peer cancer support group
in the form of 9-12 weeks seminar series to Zuckerberg San Francisco Hospital and Trauma Center
(ZSFG formally known as San Francisco General Hospital or SFGH) patients. Since ZSFG is a safetynet hospital, it serves a large underserved community. CARE provides seminars series in three
languages: English, Spanish, and Cantonese. CARE staff also supports their participants by making
home calls, reminders, and giving additional help as needed. CARE is also provided at no cost to the
participant.
History
In 2001 the SF Foundation approached the San Francisco General Hospital (SFGH) Foundation
with a donation from a donor interested in establishing programs for low-income people with cancer.
The donation was generously given to CARE by a former SFGH cancer patient. That year the executive
director of the SFGH Foundation appointed the director of patient education to develop a program. Since
October of 2002, the CARE program has provided cancer support to thousands of medically
underserved cancer patients. The CARE support group model is based on a tailored educational program
with a loving and supportive atmosphere. The English and Spanish CARE seminar series began in
October 2002. The Chinese seminar series began in 2005. Currently, CARE is a program within and
overseen by Community Wellness Program. The Community Wellness Program has its own center on
the second floor of the hospital in the Community Wellness Center across from the hospital cafeteria.
Many patient walk by this room. The Community Wellness Center houses various programs that
promote health and wellness.
The following CARE vision, mission, and objectives are presented and edited for clarity. This is
not the initial vision, mission, and goals created by the original CARE program planning team.
Vision
All cancer survivors thrive with hope and purpose throughout their cancer journey at ZSFG.
11
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To deliver humanistic, culturally, and linguistically appropriate health education and
psychosocial support.
Goals
o Build a cohesive and expanding cancer survivor community within ZSFG.
o Encourage personal awareness, so individuals can work toward fulfilling their health and
wellness needs in order to enhance their quality of life.
o Improve relationships and communication between cancer survivors and health
professionals
Funding
CARE was awarded the California Pacific Excellence in Patient Education Award and the AMA
Innovative Approaches to Patient Centered Communication Award in 2002. In 2004,
Hematology/Oncology division at SFGH along with Avon Foundation monies supported CARE staff.
Due to various reasons, CARE funding since the initial support has been tenuous. Currently CARE is
funded by a grant from AVON Foundation, and the San Francisco Department of Public Health and
ZSFG. The CARE Coordinator works 40% of full-time equivalent for CARE. The CARE Director also
works 40% of full-time equivalent for CARE. Donations for CARE are currently diminishing, so CARE
is in need of extra funding.
Service offerings
CARE provides support groups once a week for a 9-12 week long three times annually. The
topics vary, but all are related to cancer. CARE is provided in the three major languages spoken by
patients: English, Spanish, and Cantonese. Each language has its own seminar series. CARE is designed
for low-income participants, but participants can come from a range of socioeconomic statuses. At the
CARE seminars, food is provided, peer discussion is encouraged, and educational presentations are
given. English and Spanish CARE are conducted similarly. Both groups beginning with a one hour to
12
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related updates to the group. The next thirty minutes to an hour, an expert presents. Lastly, a facilitator
or volunteer participant gives closing remarks. Chinese CARE runs differently and only provides a
lengthy presentation. At the end of each CARE seminar, a healthy dinner is provided to the participants
to take home to encourage healthier eating. CARE also makes weekly calls to established and
prospective participants to see how they are doing and reminds them to come to CARE. If any CARE
participant is in extreme need they are typically referred to the CARE director. The CARE director has
health education experience, so she can provide individualized education or help the participant find the
appropriate resources at ZSFG.
Target population/Client mix
CARE accepts any cancer survivor that shows up at and registers with the Community Wellness
Center at ZSFG; however, CARE has a relationship with various ZSFG departments such as:
Hematology/Oncology, Breast Clinic, Physical Therapy, Chemotherapy, Women’s Clinic, Family
Practice, and Social Work. CARE has a closer history with Hematology/Oncology. Compared to the
General Population of cancer patients ZSFG, Oncology Patients tend to be ≥10yrs younger at diagnosis
(52 years old vs. 63 years old) and present at more advanced stages (10% v. 5%). They also tend to have
poorer survival outcomes (60% 1-year mortality v. 30% 1-year mortality) and up to 50% do not speak
English.
Providers from ZSFG clinical departments can refer patients to CARE, or cancer survivors from
the community can simply go to CARE. CARE accepts all attendees, but since CARE participants
usually come from ZSFG clinics, they tend to be lower-income, younger, have more advanced cancer,
and have fewer English language skills. CARE participants are of all racial and ethnic backgrounds.
Many CARE participants face challenges related to poverty, unstable housing, immigration status,
language barriers, literacy difficulties, substance use, and/or mental health issues. They may lack
computer literacy, access to the Internet, and/or connections to helpful people/resources. CARE
13
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participants may feel mistrust of the medical establishment and related institutions. They also may be
less disposed to asking health providers questions regarding care or treatment plan.
Culture
From experience, the support group has a loving, supportive, and uplifting culture. The
participants seem to enjoy being around peers who experienced a similar fight against cancer.
Participants find comfort with their peers’ honesty and encourage a culture of honesty and humility.
Facilitators encourage curiosity and are willing to slow the workshop to keep discussion going. The
participants enjoy CARE, but may feel at odds with ZSFG since ZSFG may not meet all of their needs
and desires given that ZSFG is a safety-net with limited resources and overstretched staff. CARE
participants have a mixture of appreciation and honest criticism of resources at ZSFG.
Agency Needs and Challenges
CARE needed evaluation of the program for two main purposes. The primary purpose is to learn
from participants how we can improve the program to meet their needs. The secondary purpose was to
do an evaluation on the efficacy of CARE to provide justification of support to current and prospective
stakeholders. CARE’s original goals were very broad and a formal program evaluation on the efficacy of
CARE has not been planned or conducted. Without best practices on evaluation CARE needed input
from researchers to conduct the evaluation.
An analysis was done to identify strengths, weaknesses, opportunities, and threats called a
SWOT analysis. A SWOT analysis is located in Appendix A. After doing the SWOT analysis, it is
obvious that lacking funds provides a significant weakness and threat because it can lead to CARE
dying. To obtain funds, it seems as if CARE should be specific on what it has achieved and how it is
achieving that, so CARE can substantiate receiving financial support. The strengths are that CARE
already has many presenter and community organization relationships, and has a loyal participant
following. CARE can use those professional relationships to help get funding. CARE can use its

14
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loyal participant followings to get feedback and support in defining CARE, evaluating CARE, and
improving the program.
Methods
Evaluation Methods
There are two major research questions for this project: first is what do CARE participants
most value about CARE, second is how efficacious is CARE in providing that value. The research
design included in-depth interviews used to address the first major question, and a pilot presurvey and post survey used to address the second major question. The pre-survey and postsurvey were chosen because there is a start and end time within each series, so there is a chance
to show changes before and after participating, and surveys can yield numerical results necessary
to easily depict the efficacy of the program to stakeholders. In-depth interviews were chosen
because cancer survivorship is complicated and the original goals of CARE were too broad to
identify specific constructs that should be measure in a quantitative survey. The data from the indepth interviews was used to develop the survey. This method was used to ensure what is
evaluated in the survey matches the needs and goals of its participants as suggested by Gottilieb &
Wachala’s 2007 systematic review on cancer support groups. It’s important to allow participants
to define goals and outcome of the program because it otherwise may not be wanted or even
obtainable by participating in a support group (Gottlieb & Wachala, 2007).
In-depth interviews
The in-depth interviews were conducted with eight CARE participants, a male and female
from the following racial/ethnic groups: African American/African, Asian/Pacific Islander,
Caucasian, and Latino/Chicano. This was a convenient sample of people who were approached by
me after a few CARE sessions and accepted my invitation to be interviewed. I went to several
CARE sessions and participated in group activities, so they would get familiar with me. Over a few
15
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weeks from May to July 2017, I introduced myself to several participants as a student researcher
who wanted to hear about their experiences in confidence. For those who accepted the invitation
to be interviewed, I scheduled interviews at a convenient time in a private room in the hospital.
The interviews were audio recorded and conducted using an interview guide and interview data
collection form. The interview lasted between 60 to 90 minutes. The names of the interviewee
were not collected and a unique record number was assigned to each interviewee instead. The
unique record number kept confidentiality and reduced bias during analysis.
The interview guide and collection form were produced with input from CARE staff, a CARE
participant, and two researchers both with qualitative research experience. The questions are
open-ended questions. Before each interview, a script was read to each participant that asked for
permission to do an interview, audio record it, and use the data for a CARE evaluation project.
Each person interviewed was told that the interview can be ended at any time and any questions
can be skipped. The interview guide and data collection form are in Appendix C. The first part of
the interview in section I and II is designed to capture what participants value about CARE by
asking question around why people came to CARE, why they returned to CARE, and what did they
gain from CARE. CARE staff suggested question about CARE’s vision and competing resources.
The third section asked participants what they think the vision of CARE should be. The fourth
section asked about how to best get feedback. The fifth was used to identify any competing
programs. The interview was then transcribed and key testimonies describing themes of the
interviews were extracted and reported.
Survey
The survey was designed after conducting interviews with input with CARE staff, a CARE
participant, and two researchers. Due to scheduling challenges, the pre-survey was piloted on July
11, 2017 the second CARE session of the summer 2017series to whoever was present at the
16
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Community Wellness Center. Due to unaligned timing of the internship and summer 2017 CARE
series the post survey was not done. During the CARE seminar on July 11, 2017 the facilitator
announced at the beginning of the session that the pre-survey would be piloted after
introductions. Prior to passing out the surveys, I announced my name, and said my survey was
designed to evaluate and improve CARE and that anyone was welcomed to do my survey if they
liked. Volunteers then passed out the survey while CARE management was not present. Surveys
and pens were offered to all who accepted it. After the survey was passed out, I let participant
know they can ask me question or feedback before we moved on with the rest of the CARE session.
Valuable feedback was then used to edit the survey included in Appendix C. Volunteer collected all
the surveys after everyone was done. It took approximately 20 minutes for all the survey to be
complete.
In the survey, it asks demographic information, type of cancer, cancer stage, and place in
cancer care continuum need for CARE. The pre-survey asks for name, but this was only done by
request of CARE staff, so CARE staff can identify if someone is in dire need. The name, however,
was removed and a record number was provided before pooling data together and analyzing for
this study. This was used to ensure confidentiality and reduce biases in analysis and reporting.
Additionally, at the top of the survey it states that the survey is confidential, will be combined into
a report for CARE improvement, and will not affect participants’ participation in CARE. This
statement is used to show there will be confidentiality, and to elicit a more honest response.
From interviews, social support seemed to be a theme, with all eight participants speaking
about receiving support from other cancer survivors. Therefore, the survey used an adapted
validated perceived social support survey tool with Cronbach’s alpha of 0.88 (Li, Chen, & Popiel,
2015). The scoring for analysis method was also adapted for simplicity. To cross-reference the
findings of the interviews, a question on the main reason for coming to CARE was added. It was
17
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used to make sure peer support is relevant to the large non-interviewed group. Other information
outside of the scope of the project was also collected by the request of CARE staff. Questions on
when they learned about CARE was out of the scope, but was included to determine challenges in
outreach. After the pre-survey was conducted, two CARE participants gave feedback mainly on the
Likert scale wording, so the second pre-survey version and post-survey were modified based on
this feedback. Only the pre-survey results are reported in this paper since the seminar series
extends beyond the project deadline.
The post-survey is shown in appendix D. In addition to the components of the survey
mentioned above, the post-survey asks participants to inventory the variety of benefits gained
form participating in CARE. This inventory was added to attempt to quantify the number of people
gaining certain health-related benefits. This component was important to add so that it can be
used to substantiate support from stakeholders interested in health-related outcomes. The postsurvey will be done the last day of the summer 2017 CARE series and will not be reported in this
paper.
Results
In-depth Interview Findings
There were eight in-depth interviews each with a record number 001 to 008. Table 2 shows each
record number’s demographic information, cancer types and stage, and year diagnosed with the cancer.
Male and females from African American/African, Asian/Pacific Islander, Caucasian, and
Latino/Chicano racial/ethnic groups were interviewed. The average age of the interviewees was 59
years old. The ages ranged from 51 to 69 years old. Most were diagnosed in 2016. The earliest diagnosis
was in 2006 and the latest was in 2016. Three out of eight had stage 4 cancer. Stage 1 and 2 as well as
people without a stage were represented. Interviewees had a variety of diagnoses, but three had breast
cancer and two had myeloma. Most had 1 type of cancer. One person has cancer in multiple organs.
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Table 2
In-Depth Interviewee Demographics And Cancer Diagnosis Information
Record number
Gender
Age
Race/Ethnicity
Cancer type,
(M for male,
Stage
F female)
001
M
52
Latino/Chicano
Myeloma,
Unknown
stage
002
M
57
Caucasian
Colon, Stage 4

Year
Diagnosed
2016
2016

003

F

53

Latino/Chicano

Lung, Stage 4

2016

004

F

69

Caucasian

Breast, Stage 2

2015

005

F

59

Asian/Pacific
Islander

Stomach,
Ovary, Breast,
Stage 4

2006

006

M

69

African/African
American,
Caribbean

2009

007

M

60

Asian/Pacific
Islander

Chronic
Lymphocyte
Leukemia, No
Stage provided
Breast, Stage1

008

F

51

African/African
American

Multiple
Myeloma, No
stage provided

2011

2016

In the in-depth interviews we asked how best to get feedback from CARE participants; most
people said in-session surveys were best with a minority of people suggesting direct feedback. Four out
of eight said paper surveys fielded during CARE sessions works well. Three said they prefer to give
direct feedback in person to CARE staff. One said he didn’t feel comfortable giving feedback at all. A
few suggested other survey designs. Two suggested having short surveys. One suggested having a
survey online, so it can be completed anytime. Table 3 provides quotes showing preferences for giving
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feedback to CARE staff about CARE performance. From the surveys, two points to keep in mind
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include length and time allotted to complete the surveys.
Table 3
In-Depth Interview Quotes On Feedback Preferences
Main questions/
Quotes
comment type
How would you like “You have that exit survey, which is good since things are fresh in your mind, so
to give feedback to if I had something to say I can use that form. I think a survey is more important
CARE? than having a [comment] box, so everyone does it.” —57 year old Caucasian
Male, Stage 4 Colon Cancer Survivor
“Its okay. They have the survey, but they are rushing.”—59 year old
Asian/Pacific Islander Female, Stage 4 Stomach, Breast, and Ovary Cancer
Survivor
“I like the one on one approach. I know I can talk to anybody there. I would like
to come up to you...I know I have [the CARE manager’s] office number and I
can call her. I haven’t called, but I have her number”—69 year old Caucasian
Female Stage 2 Breast Cancer Survivor
Design of survey “Do one of the survey things online with like 10 questions and say it take 5
minutes, so you know. Otherwise you can take a survey and its like oh my god,
its so many questions.” —57 year old Caucasian Male, Stage 4 Colon Cancer
Survivor

There were several questions asked to determine what is most valued and gained from
participating in CARE, including questions about why people joined CARE, what they feel is the best
part of CARE, and what makes them return to CARE. All eight interviewees mentioned how important
it was for them to gain social support from other cancer survivors in the CARE program. Some
mentioned education as being important as well. Table 4 and Table 5 shows quotes presented
thematically to illustrate what value CARE brings to its participants. Those interviewed talked about
how important speaking to cancer survivors is to gaining things such as experiential knowledge of what
is to come, hope, inspiration, acceptance of diagnosis, and emotional support. Participants felt these
were things doctors couldn’t necessarily give, but peer cancer survivors from CARE could. Social
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support from CARE seemed to drive people to have positive changes that could affect their health such
as feeling less anxious, sleeping better, managing life better, and improving emotional wellbeing.

Table 4
In-Depth Interview Quotes Regarding the Value Gained From CARE
Main questions/
Quotes
comment type
Why did you “My daughter she doesn’t get it. People don’t get it. My friends are like what do
decide to join you mean you have cancer, you don’t have cancer, you’re a cancer survivor. But
CARE? somewhere in my mind its still there. Did it all go away? No! I still have to take
medicine. I still need to go to therapy. And my life in still in the drain. So, it’s
still like I am going through it. I am still dealing with the pain relating to this,
[cancer]… I thought it would be good to be around other [cancer survivors].”—
69 year old Caucasian Female, Stage 2 Breast Cancer survivor
“When you are really sick you need someone to talk to because in your family,
sometimes it is hard to discuss what your feeling is, but with others with the
cancer its like they know what your are feeling.”—59 year old Asian/Pacifica
Islander Female, Stage 4 Stomach, Ovary, and Breast Cancer Survivor.
“My father was a psychologist, so I know how important these things are on a
emotional level, on a educational level I know these support groups can be
really important. Plus there are details only people going through these things
can understand. And so that feels good. It feels nurturing to find people.” —57
year old Caucasian Male, Stage 4 Colon Cancer Survivor
What about “I thought it would be good to be around other [cancer survivors] and it was. I
CARE keeps you am very private person, so it was special.”—69 year old Caucasian Female,
coming back? Stage 2 Breast Cancer Survivor
“The people keep me coming back because people care. You get to know people
and they are my friends now. You know we have this time every week. If you
missed it and you are like damn I missed CARE. Its the camaraderie and
everyone is having a good time.”—51 year old African American Female,
Multiple Myeloma
The recurring theme of the in-depth interviews indicated that social support is vital to CARE and
should be examined further. Participants stated they are coming to CARE for social support and
information they cannot get from their physician, and that participants are returning to CARE because
CARE has a caring, understanding environment with a sense of camaraderie and it can be fun.
Participants believed they are getting the support that is good for the body and the soul, they are feeling
21
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less anxious, sleeping better, managing their life better, and getting hope and emotional support. Social
support may not only be key to understanding how efficacious CARE is, but it may indicate that other
health promoting benefits being gained from participating. From the testimony it seems like social
Table 5
In-Depth Interview Quotes Regarding the Value Gained From CARE
Main questions/
Quotes
comment type
What have you “There are details only people going through these things can understand. And
gained from so that feels good. It feels nurturing to find people [other cancer survivors]…I
coming to think that type of support we have in CARE and that type of networking its good
CARE? for the soul. What’s good for the soul is good for the body. Healthy mind,
healthy body”.—57 year old Caucasian Male, Stage 4 Colon Cancer Survivor.
“[CARE], it made me feel less anxious and that I am not alone. It’s a big thing
because like I said my daughter and my friends don’t quite get it. I am feeling
like someone gets].”—69 year old Caucasian Female, Stage 2 breast cancer
survivor
“I [benefitted from CARE] by accepting [my cancer]. I hear other people
speaking about it and they are more sicker and they survive. They are my
heroes. I cannot sleep because I no accepting, but now I accepting—I sleep a
little bit more. Also the medicine helping me. When you are accepting why are
you sick, you are accepting why you are tired, you accepting why [you have
symptoms], you accepting that people look at you different.”— 53 year old
Latina Female, Stage 4 lung cancer survivor
“CARE got me to a point where I can manage my life again and give back and
try to help people. There are a couple members in the group that I talk to when
they first came in and there were people who talked to me when I first came
in…There is a sense of commonality, comfort, and support that people have
toward one another that they get for themselves.”—69 year old African
American and Caribbean, Chronic Lymphocyte Leukemia
“When you meet many people who are surviving. It gives you hope. It is
probably the biggest thing I gotten from CARE is the hope [from other cancer
survivors]. It has definitely affected me emotionally.”— 51 year old African
American Female, Multiple Myeloma
support may indicate small improvements in social wellbeing, emotional welling, physical wellbeing
and more.
Pre-survey Interview Findings
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There were 25 pre-surveys done with a few not being fully completed. Table 6 shows the
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demographic statistics for age, gender, race/ethnicity, and financial stability. The average age was about
62 with the youngest being 50 years old and the oldest being 79 years old. There were more females
than males. The largest racial/ethnic group was Asian/Pacific Islanders followed by Caucasians and
African/African Americans. Most who were surveyed are somewhat financially instable.
Table 6
Pre-survey Demographic Information
Age
Average (Range)
Gender
Percent (Number)
Race/Ethnicity
Percent (Number)

62(50-79) years old
Male: 40%(10)
African/African
American
Asian/Pacific Islander
Caucasian
Latino/Chicano
Other

Female 60%(15)
17%(4)
42%(10)
29%(7)
8%(2)
4%(1)

Financial
instability

Instable
12%(3)
Somewhat instable
64%(16)
Stable
24%(6)
Cancer types, stages, and places in cancer continuum and shown in Table 7 located in appendix
E. Participants indicated they have single and multiples cancers. Stages 1 to 4 were represented and
some did not indicate their stage or did not have a diagnosis with a stage. Stage 4 had the highest
representation and Stage 1 had the lowest. There were ten different cancers represented with the most
common being breast cancer, followed by chronic lymphocyte leukemia and lung cancer. People were in
various places in the cancer care continuum, but the most common place in done with treatment for over
a year with the second most common place being currently in treatment within the last 6 months.
Data on how familiar people were with CARE and how long they have attended was collected.
Table 8 in appendix F shows how familiar participants are with CARE and how long they have been
members of CARE. Most were CARE veterans meaning they were very familiar with CARE. The
CARE veterans had an average of 7 years participation in CARE and ranged from 2 to 11 years in
23
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CARE. A few said they were new to CARE and on average spent only 1 month in CARE. The average
length of membership was 3.5 years with the longest being 11 years, and the shortest being brand new to
CARE. This information may be valuable to examine the dosage effect.
Data on perceived social support from an adapted perceived social support survey tool included
in the pre-survey was collected and converted into quantifiable data. The social support survey tool had
five items scored by Likert scale using a converted numerical score -2 to 2, with -2 being the lowest
score and 2 being the high score for each item. In total the lowest possible score was -10 indicating the
lowest perceived social support and the highest possible score was 10 indicating the highest perceived
social support. From the surveys, the average perceived social support score was about 5, with the
highest being 10 and the lowest being -5.
Table 9
Reasons participants joined CARE
Main reason for joining
CARE
To talk with other cancer survivors who
Percent (Number)
understand
To get emotional support

70%(19)
63%(17)

To learn about cancer from presenters
63%(17)
To get connected to resources
30%(8)
To get a healthy dinner
33%(9)
Other
11%(3)
There were a variety of reasons people joined CARE. Most people selected more than 1 reason.
Table 9 shows the reasons, and the percent and number of participants who selected each reason. The
most common reason people came was to talk to other cancer survivors who understand followed by to
get emotional support and learn about cancer from presenters. A minority of participants joined CARE
to get connected with resources and to get a healthy dinner. A few selected other and wrote something
about sharing and inspiring others battling cancer. The data showed that not only was social support
important to the interviewees, but also to the majority of people who were surveyed. This aligns with
what was seen in the in-depth interview.
24
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The project goal was to evaluate CARE, a peer cancer support group. The project was necessary
since CARE staff needed to understand the efficacy of the program in order to substantiate stakeholder
support and to improve the CARE program. In order to evaluate it, in-depth interviews were conducted
to discern value CARE provides to its participants. From the interviews social support seemed to
provide the most value as it was most commonly mentioned as the reason people came to CARE and
returned to CARE, and it was what participants gained from CARE. This led to us using a perceived
peer survey tool in our quantitative survey. By evaluating perceived social support, it can help CARE
staff understand how much social support CARE participants gained. The survey may also assist CARE
staff in improving the program by helping them decide to further focus on social support.
The in-depth interviews were key to conducting this evaluation because it brought CARE
participants’ voices into the discussion around how to determine CARE’s performance. Understanding
the efficacy of CARE from the lenses of participants aligns both program and participants goals. It also
led to the design of the survey. I recommend collecting qualitative data like the quotes collected from
the in-depth interviews because it gives detail explanations on what participants want from the peer
support group, and why they want it and why it is important.
The quantitative surveys were key in accomplishing the project goal because it corroborates what
was heard in the in-depth interviews, and it provides information CARE staff need. Both the in-depth
interviews and surveys indicated that social support is desired. Social support was the main reason why
people participate in CARE. Since particular stakeholders want quantitative data, the quantitative survey
results meet CARE staff needs. The quantitative data can address a major threat to CARE of not having
quantitative data to defend the support of the program, and possibly not being able to obtain the support
of stakeholders and expanding funding sources. The quantitative data can be used to justify and improve
new and existing stakeholder support.
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program. The reasons include complexity of cancer survivorship, diversity of support needed, and board
goal of the CARE program. This set of challenges made it hard for a researcher and a community
program designer to determine the type of evaluation needed to assess program performance and
participant needs. If other peer support programs have a similar challenges as CARE, I recommend
collecting qualitative and quantitative data similar to what is shown in this paper. In-depth interviews
informing the quantitative survey development seemed to work well for the project goal and the CARE
staff needs.
Discussion
Developing the evaluation of CARE was not a simple task. The program and lack of literature
provided challenges. The program provided challenges since the original vision, mission, and objectives
were broad and needed some revision. They could not be used to specify what constructs need to be
evaluated. The lack of literature provided challenges since limited standard methods and survey tools to
evaluate cancer support groups were identified. No best practices on evaluating peer cancer support
groups such as methods and tools were known. To address this challenge, in-depth interviews were
conducted to help inform the survey development. Questions from the in-depth interview were designed
to determine what CARE participants’ value the most from attending CARE. Social support was a
recurring theme in all the in-depth interviews, so the perceived social support construct was used to
make quantitative surveys that could evaluate CARE’s performance and give clues to what needs
improving. Social support seems like a promising construct because the surveys showed that
participants’ main reason for joining CARE indeed was to talk with others. The social support construct
is also promising because CARE participants testimonies show the variety of benefits gained from social
support that range from social benefits, emotional benefits, physical benefits, and to even more. There
even can be a possibility these benefits are health and wellbeing related.
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The challenges I faced and my findings were also seen in the literature. In the Campbell,
Phaneuf, & Deane, 2004 systematic review, the authors discussed the challenges researchers had in
evaluating peer support groups. Campbell, Phaneuf, & Deane’s 2004 review discussed how studies
lacked a thorough and clear description of the program, and had methodical flaws amongst other
challenges. A different systematic review on cancer support groups also discussed the methodical
challenges, but went on to suggest that methodical problems could be due to the inappropriate outcome
measures used (Hoey, Ieropoli, White, Jefford, 2008). Another systematic review summarized
evaluation issues in three parts that link the methodical flaws with program plan flaws (Gottlieb &
Wachala, 2007). The first is that the cancer support group planner needs to be clear as to whether the
group is supposed to cause the outcome of interest or be the stepping-stone toward the outcome
(Gottlieb & Wachala, 2007). The second is that the program planners rarely consult participants in
determining the desired outcome, which could result in nonmatching desired outcome (Gottlieb &
Wachala, 2007). The third is attrition and performance may be low if program planners don’t match
their outcome goals and measures with goals desired and expected by the participants (Gottlieb &
Wachala, 2007). The challenges reported in the literature regarding program design and evaluation
design is similar to challenges seen in CARE prior to this project.
Addressing Challenges
I addressed the evaluation design challenges stated above by seeking the CARE participants’
input. By interviewing them, I allowed them to tell me in their own words what mattered to them and
what value CARE brought to their lives. Social support was what they were after, needed, and what they
gained from CARE. The perceived social support construct was actually different from what I and
CARE staff were initially thinking of measuring. Initially, we were thinking of measuring health-related
quality of life, but there were issues with using that measure since a lot more than the cancer support
group affects quality of life. The reason why we were attracted to health-related quality of life construct
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stakeholder would be most satisfied with this construct Health-related quality of life was initially
thought of since the ultimate goal of the hospital is to improve the health of the community. However, if
quality of life were selected the change between the pre-survey and post survey may report no or
negative change, not accurately reflecting the efficacy of the program. There might be no or negative
change in health-related quality of life if other factors such as disease progress or financial burden
happens to negatively affect CARE’s participants during the study. Given our population is vulnerable,
there is a high chance this can happen. A poor selection of construct to measure can lead to poor
reporting of efficacy and lost support for CARE, a possible result not necessarily warranted.
Instead of choosing health-related quality of life, we decided to allow participants to choose the
construct by telling us what they valued and gained from CARE. This approach solves some of the
challenges regarding disconnect between participants goals and program planner goals. The social
support construct is a much more appropriate measure because it aligns the desired outcomes of the
CARE peer cancer support group as well as the participants. From qualitative evidence, it seems like
social support is more obtainable with CARE, and it accurately describes what participants get from
CARE. Our methods solves challenges stated in Gottlieb & Wachala’s 2007 review because we know
social support can be a step toward health-related benefits as described above, social support is
something both us and participants are interested in, and this alignment of interest can improve
programing in the eyes of both the program planner and participants.
Limitations
There are several limitations in conducting a full rigorous evaluation of CARE. A major
limitation had to do with the timing. The projected needed to be done within the period of an internship,
but that did not match up with the CARE seminar series; therefore, only the in-depth interviews and presurvey was done. The post survey will be conducted at the end of the CARE summer seminar series in
late August 2017. Another timing issue had to do with when the pre-survey was conducted. The pre28
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survey was not conducted the first day of the summer seminar series due to prior commitments CARE
staff made to presenters. However, if the pre-survey was done on the first day there may not be enough
time to have all the schedule presenters and field the survey. On the second day there was ample time to
finish the survey. A limitation of conducting the pre-survey on the second day is that, it might not reflect
what social support was before coming to CARE. Peers may have connected on the first day and the
perceived social support might have increased, so the change in perceived social support might show as
lower between the pre-survey and post-survey.
There were sample limitations. Since there were only eight in-depth interviews and 25 presurvey participants, the data might not have reflected what would be seen if all of CARE participants
were interviewed and surveyed. With this small sample size, nothing definitive and statistically
significant can be said about the CARE program. The sample was also a convenience sample of those
willing and able to complete the in-depth interviews and pre-survey. I did not sample all the CARE
participants, only people who were present and willing to be sampled. I also did not compare perceived
social support of the CARE participants with ZSFG cancer survivors who do not attend CARE.
Comparing perceived social support between those two groups can help demonstrate how perceived
social support differs between CARE participants and non-CARE participants. Also since ZSFG cancer
patients are unique and tend to be low-income and vulnerable, generalizing the findings to other cancer
support groups is not advisable.
There are limitations in regards to the design of the survey. Written survey might also not be the
best for those who lack literacy. Since the surveys were completed during the CARE session, people
might not be fully truthful. Steps were taken to try to reduce pressure felt on displeasing staff by having
interns and volunteers pass out and collect surveys. Survey were given during the session, so people are
motivated to do it at that moment instead of taken home and forgotten. Asking for names on the survey
may be a big limitation. People might not want to be fully truthful since they identified themselves and
do not want to be too displeasing. Ways I tried to address this anxiety from writing their names on the
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CARE.
Another limitation of the project is that social support might not be what potential stakeholders
from ZSFG want to know. Since CARE is housed in a hospital where health is of primary interest,
perceived social support may not be what stakeholder want to know. Instead they might want something
akin to health-related quality of life, but this construct is complicated to use for a program evaluation in
ways discussed previously. One way we address this issue is by reporting ways social support has
affected health-related factors such as sleep, emotional stability, and more as described by CARE
participant testimony. In addition, there are many studies showing the linkage of social support with
health-related benefits (Eisenberger, 2013).
CARE Recommendations
I recommend that CARE continue to investigate the social support aspect of CARE. It was
shown to be a highly valued feature of CARE. A major reason people come to CARE is to speak with
other cancer survivors. Both the in-depth interviews and the surveys showed that. Social support may
also be promising because it can be a steppingstone to other desired health-related benefits such as
improved sleep and emotional wellbeing. There may be other health-related benefits not captured in the
interviews that use social support as a vehicle to improve health, so that should be explored. The
mechanism seems to be that participants are getting social support from cancer survivors at CARE then
getting experiential knowledge from others, gaining camaraderie, and building hope— leading to a more
peaceful and productive life. This mechanism can be further explored and described to gain stakeholder
support.
Having a short paper survey available during sessions seems the most sensible for obtaining data
from CARE participants. Participants seemed to be okay with the paper surveys and even said it was
best to complete the survey during CARE, so feedback is fresh in their minds. Giving immediate
feedback may be important as ZSFG cancer survivors have many adversities and may not have the time
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DEVELOPING A PEER CANCER SUPPORT GROUP EVALUATION
31
to complete the survey later. Short, clear and concise surveys are preferred since long surveys may be
disliked by participants and may not get completed. Paper survey also were preferred since some CARE
participants are older and may not be used to taking electronic surveys; however, in the future CARE
participants may be open to online or electronic surveys.
CARE staff should use the surveys provided or design a survey similar to the one provided in the
future. From the pilot pre-survey feedback, the post-survey can be improved by using a simpler worded
Likert scale for the perceived social support survey. The wording is already modified in the surveys
provided in appendix C and D. The previous wording in the pilot pre-survey made at least two CARE
participants confused, so rephrasing was needed. Following the design of the post survey in appendix C
and D for future surveying can help.
To satisfy certain stakeholders who needed health-related quantitative results, taking an
inventory of health-related benefits since attending CARE may help. In the post-survey there is an
inventory of health-related benefits; however, this inventory can expand. I suggest noting other healthrelated benefits and adding it to this inventory, so that information is captured. Showing the number and
percentage of those gaining various health-related benefits may be what certain stakeholders want.
Suggestions for Research
Currently literature does not provide a standard method to evaluate peer cancer support groups,
so I suggest further research to make this possible. Research would need to bring many different key
stakeholders together such as program planners, funders, cancer care experts, cancer survivorship
research experts, and most importantly cancer survivor social support participants. Ideally, what is
evaluated should be a common construct of interest held by all the stakeholders listed.
A gold standard quantitative survey tool that measures efficacy of peer caner support groups can
make evaluation easier. More research should be done to work toward a gold standard survey tool.
Having such a tool can make it easier to conduct a survey and compare programs. A standard survey
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designs, populations of cancer survivors, and other complicating variables.
Another important suggestion for cancer support research is to understand the mechanisms of
how peer support amongst cancer survivors leads to health benefits. A goal of some peer cancer support
programs is to improve health. Therefore, understanding mechanism for adopting healthier practices
through peer influence may be key in knowing what it takes to improving health and programing. To
understand these mechanisms it is appropriate and necessary to employ qualitative research methods that
gives more descriptive information.
Once extensive research is done on social support group evaluation, I urge an authority in cancer
care to provide best practices on evaluation. This should include evaluation methods, quantitative survey
tools, and justification on why these best practices work. If it is outlined, more peer cancer support
groups can conduct rigorous and accurate evaluations. This type of evaluation can help peer cancer
support group gain sponsor support, and improve programing.
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SWOT Analysis Table
SWOT Analysis Table
Table analysis strengths, weaknesses, opportunities, and threats
Strengths

Weaknesses

•

CARE has loyal participants who have been
coming for years

•

•

CARE is one program within the Community
Wellness Program that has many health and
wellness promoting programs
CARE is in ZSFG which is where participants
get medical care

•

•

CARE has established a network of loyal
guest speakers

•

•

CARE gets referrals from clinics and partners
with clinical departments

•

•

CARE already has relationships with
foundations that could fund

•

•

Opportunities
CARE staff can ask participants and guest
speakers for feedback

•

•

•

CARE staff could get advice and feed back
from non-CARE Community Wellness staff
that run community based programs
ZSFG clinical staff and CARE staff can work
together to serve CARE participants

•

•

CARE would work with community
organizations outside of ZSFG to gain support

•

•

The foundations that have a relationship with
CARE can give CARE feedback on the
program and advise on how to gain more
support, especially financial support

•

•

•

•

CARE was created when there was little
cancer survivorship research on best
practices
CARE’s mission and goals are very broad

CARE staff has not done an extensive
formal evaluation capturing what
participants consider most valuable about
CARE
CARE has not created evaluation
protocols based on a standard
CARE is not getting many referrals from
other clinics such as Urology, Geriatric
Clinic, Neurology, Pain consultation,
Plastic Surgery, Pulmonary, and
Dermatology
CARE’s pool of endowment money have
been diminishing
Threats
There is no national standard method and
survey tool to evaluation cancer peer
support groups
If CARE does not get funding it need to
operate, CARE could die
CARE participants have limited resources
and knowledge to help CARE initiatives
continue by themselves
Clinics referring to CARE are not getting
updates from CARE and they may not see
how CARE participants’ health or
wellbeing are improving
It may be hard to substantiate sustaining
CARE if other cancer support programs
offer the exact same value.
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Appendix B

Interview Data Collection Form
Interview number: _____
Date conducted: __-__-____ (MM-DD-YYYY)
Interviewer: ________________________________
Interviewee information:
Type of cancer(s):________________ Date diagnosed: __________
Interviewee gender: ________
Interviewee age: _______
Interviewee racial/ ethnic group (Circle One): Asian/Pacific Islander American
African American
Caucasian American
Latino American
Other (describe):
Number of times attending CARE: ___________
Date of last CARE session attended: __-__-____ (MM-DD-YYYY),
CARE session topic: ___________
Notes:
Reasons Participants Attend CARE, Return to CARE, and Enjoyed About CARE:
I.

INDIVIDUAL CIRCUMSTANCES AND NEEDS
a. Circumstances and Needs
i. Tell me about your experience being diagnosed with cancer.
Probe: 1. What were you most concerned about when you were diagnosed?
2. What did you need help with once you were diagnosed?

_________________________________________________________________________________________________________________
_________________________________________________________________________________________________________________
_________________________________________________________________________________________________________________
_________________________________________________________________________________________________________________
_________________________________________________________________________________________________________________
_________________________________________________________________________________________________________________
_________________________________________________________________________________________________________________
_________________________________________________________________________________________________________________
_________________________________________________________________________________________________________________
___
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CARE EXPERIENCE
a. Getting involved
i. How did you end up getting involved CARE?
Probe: 1. How did you hear about CARE?
ii. Why did you decide to come to CARE when you did?
iii. About how many CARE sessions have you been to? OR How long have you
participate in CARE?
iv. How long do you plan to participate in CARE?
Probe: 1. [If they plan to return] What keeps you coming back to CARE?
2. [If they plan to return] What are things that prevent you from coming to
CARE?

_________________________________________________________________________________________________________________
_________________________________________________________________________________________________________________
_________________________________________________________________________________________________________________
_________________________________________________________________________________________________________________
_________________________________________________________________________________________________________________
_________________________________________________________________________________________________________________
_________________________________________________________________________________________________________________
_________________________________________________________________________________________________________________
_______________________________
b. Expectation and feedback on CARE sessions
i. Before you got involved with CARE, what did you hope to learn or get from CARE?
1. When you joined CARE was there anything you experienced in the CARE
Prob
group that surprised you? If so, what was it?
ii. In general, how would you describe your experience?

1. What is the best part of CARE?
2. What part of CARE would you change?
_________________________________________________________________________________________________________________
Probe:

_________________________________________________________________________________________________________________
_________________________________________________________________________________________________________________
_________________________________________________________________________________________________________________
_________________________________________________________________________________________________________________
______________________________
c.

Value obtained by CARE
i. How have you benefitted from participating in CARE?
ii. What do you gain from being a part of CARE?
1. How did your experience with CARE affect your life?

Probe:
_________________________________________________________________________________________________________________
_________________________________________________________________________________________________________________
_________________________________________________________________________________________________________________
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_________________________________________________________________________________________________________________
__________________________________________________________
Suggestions for CARE:
III.
OPINION ON THE VISION OF CARE
a. Developing the Vision of CARE with the participants
i. We are working on a motto that summarizes what CARE stands for. In
one phrase describe what CARE should stand for?
Probe: 1. What should CARE’s motto be?
_________________________________________________________________________________________________________________
_________________________________________________________________________________________________________________
_________________________________________________________________________________________________________________
_________________________________________________________________________________________________________________
_________________________________________________________________________________________________________________
_________________________________________________________________________________________________________________
__
IV.

GETTING FEEDBACK
b. Asking for feedback in the future
i. If you had a suggestion or a comment about a CARE session, how would
you communicate it?
Probe: 1. Would you feel comfortable giving feedback in person to staff? If so,
who?
2. Would you feel comfortable giving feedback on the phone?
3. Would you feel comfortable giving feedback in a survey, online or
paper, after the CARE session?
4. Would you feel comfortable giving feedback through an anonymous
comment box?
c. Feedback on CARE
i. Is there anything else you want to share with me about CARE?

_________________________________________________________________________________________________________________
_________________________________________________________________________________________________________________
_________________________________________________________________________________________________________________
_________________________________________________________________________________________________________________
_________________________________________________________________________________________________________________
_________________________________________________________________________________________________________________
_______________________________________________________________________________________
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Other competing support programs:
V.
OTHER RESOURCES
a. Other resources used by CARE participants
i. What other support programs are you involved in?
Probe: 1. What do you get from that support program that you don’t get from
CARE?
ii. If CARE didn’t exist where else or how else would you get the support you
get from CARE?
_________________________________________________________________________________________________________________
_________________________________________________________________________________________________________________
_________________________________________________________________________________________________________________
______________________________________________________________________________________
Closing statement: Thank you so much for participating in this interview. The information
you provided is valuable and will help CARE evolve, so CARE can provide the best support to
its participants.
In the future, if you have questions, comments, or need support, please contact me at
Glenda.Kith@sfdph.org or come to the Community Wellness Center.
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CARE Pilot Pre-survey (English)
This survey is confidential. It will be combined into a report, and provided to CARE
for program improvement. Your responses will NOT affect your participation in
CARE.
1. Name: First, Last initial _____________________, ____.
2. What is your age? _________

3. Gender:

Male

Female

Other

4. Race/Ethnicity: (Check ALL that apply)
African American/African
Caucasian
Asian/Pacific Islander
Latino/Chicano
5. Are you: (Check ONE)
(1)New to CARE
(2)Somewhat familiar with CARE
(3)CARE Veteran
5a. How long have you attended CARE (months/years)? ______/_______
6. Describe your circumstances when you first joined CARE: (Check ONE)
I have been diagnosed with cancer
I have not been diagnosed with cancer, but I am a family
member/friend of someone diagnosed with cancer. If you selected this
option SKIP question 7.
Continue to the next page.
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7. Where are you in the cancer process? (Check ALL that apply)
Diagnosed with
cancer in the last 6
months

Currently in cancer
treatment
Within last 6 months

Done with
treatment in the
previous year

Done with
treatment
over a year ago

8. Who told you about CARE? (Check ALL that apply)
Friend
Medical Provider
Cancer Navigator
Social Worker
Community Wellness Center Staff
Other: __________________
9. Do you feel you heard about CARE…
Too early
At the right time
Too late
Why?:____________________________________
10. In the past 12 months I was in extreme financial need and didn’t have
money to pay rent, housing bills, food and/or medicine…
Often True
Sometimes True
Never True

Continue to the next page.
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11. What is the main reason you first came to CARE? (Check ALL that apply)
To talk with other cancer survivors who understand
To get emotional support
To learn more about cancer from presenters
To get connected to resources such as meal assistance, housing, etc.
To get a healthy dinner
Other: __________________________________________________
Below is question regarding social support (Check one box in each line)
12. Please read each statement
and indicate how much you
agree of disagree.

Definitely
Yes

Yes

Neither
yes or no

No

Definitely
No

12a. I know someone I can
confide in about my problems
relating to cancer.
12b. I have someone who can
give me advice on crises
relating to my cancer.
12c. I have someone who gives
me information to help me
better understand my cancer.
12d. I have someone to help
with daily chores if I was sick.
12e. I have someone I can have
a good time with.
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12. Tell us how you hope CARE could help you improve your life.
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________

13. What cancer do you have? (OPTIONAL, Answer only if comfortable)
Stage:

Stage 1

Stage 2

Stage 3

Stage 4

Last Page.
Thank you for participating!
This information will help us improve CARE.
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CARE Post-survey (English)
This survey is confidential. It will be combined into a report, and provided to CARE
for program improvement. Your responses will NOT affect your participation in
CARE.
1. Name: First, Last initial _____________________, ____.
2. What is your age? _________

3. Gender:

Male

Female

Other

4. Race/Ethnicity: (Check ALL that apply)
African American/African
Asian/Pacific Islander
Caucasian
Latino/Chicano
5. Are you: (Check ONE)
(1)New to CARE
(2)Somewhat familiar with CARE
(3)CARE Veteran
5a. How long have you attended CARE (months/years)? ______/_______
6. What is the main reason you first came to CARE? (Check ALL that apply)
To talk with other cancer survivors who understand
To get emotional support
To learn more about cancer from presenters
To get connected to resources such as meal assistance, housing, etc.
To get a healthy dinner
Other: __________________________________________________
Continue to the next page.
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7. Attending CARE has prepared me to…

48

Agree Disagree Neither
agree or
disagree

7a. Better accept my cancer diagnosis
7b. Select a cancer treatment plan
7c. Better manage my side effects (such as pain, focus,
etc.)
7d. Emotionally deal with my cancer
7e. Eat healthier
7f. Sleep better
7g. Exercise more regularly
7h. Communicate better with my health provider
7i. To connect with other cancer support programs
(such as Project Open Hand, Second Opinion, etc.)
7j. Communicate better with my loved ones about my
cancer
7k. Become more productive at work or home
7l. Be more aware of my physical, mental and
emotional issues

7m. Other: Specify:_________________________
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Continue to the next page
Below is question regarding social support (Check one box in each line)
8. Please read each statement and
indicate how much you agree of
disagree.

Definitely
Yes

Yes

Neither
yes or no

No

Definitely
No

8a. I know someone I can
confide in about my problems
relating to cancer.
8b. I have someone who can
give me advice on crises relating
to my cancer.
8c. I have someone who gives
me information to help me
better understand my cancer.
8d. I have someone to help with
daily chores if I was sick.
8f. I have someone I can have a
good time with.
9. What would you like CARE to change? (Check all that apply)
More time to check-in in a group if people have updates and news to tell
Having more time to socialize at the end
Having CARE staff drop-in office hours
Healthier food choices
Other (if no changes desired write “None”):___________________________
10. What cancer do you have? (OPTIONAL, Answer only if comfortable)
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Stage:

Stage 1

Stage 2

Stage 3

50

Stage 4

11. Do you have comments or feedback on CARE?

Last Page.
Thank you for participating! This will help us improve CARE.
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Appendix E
Table 7
Pre-survey Cancer Information
Cancer type
Breast
Chronic Lymphocyte Leukemia
Colon
Gallbladder
Lung
Lymph
Myeloma
Stomach
Thyroid
Tongue
Prefer not to say
Stage
Stage 1
Stage 2
Stage 3
Stage 4
No stage indicated
Place in Cancer
Continuum
Diagnosed with cancer 6 months ago
Currently in treatment within the last 6 months
Done with treatment in the previous year
Done with treatment over a year ago
Nothing indicated

6
2
1
1
2
1
1
1
1
1
8
1
5
2
7
10
3
8
3
9
3
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Appendix F
Table 8
Familiarity with CARE
Familiarity
with CARE
Percent
(Number)
New to CARE
Somewhat Familiar with
CARE
CARE Veteran
Length of
CARE
membership
Average
number of
years (Range)
3.5 years (0-11 years)

21%(5)
29%(7)
50%(12)
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